CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Multicenter Dose Escalation and Dose Expansion Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer - KisMET-01

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05652868
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:49.806526+00:00
Published At: 2025-12-16T00:00:00+00:00
Record Updated At: 2025-12-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["NSCLC", "NSCLC Stage IV", "NSCLC Stage IIIB", "Non-Small Cell Lung Cancer", "Advanced Non-Small Cell Squamous Lung Cancer", "Advanced Non-Small Cell Lung Cancer", "Advanced Non-Small Cell Non-Squamous Lung Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-12-16"
protocolSection.identificationModule.nctId: "NCT05652868"
protocolSection.identificationModule.officialTitle: "A Phase 1 Multicenter Dose Escalation and Dose Expansion Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer - KisMET-01"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.